- $37.77bn
- $45.25bn
- $32.72bn
Trading Update – April 2023
Holding(s) in Company
EU permits to boost profitability in cement though volumes fall - GS
CRH to quit Dublin exchange - Irish Times
Director/PDMR Shareholding
UK's OKYO Pharma plans to delist from London in May (updated)
Brief: CRH Completes Latest Phase Of Co's Share Buyback Programme
Director Declaration
AGM Notice and Form of Proxy
CRH Announces Non-Executive Board Appointment
Annual Financial Report
Director/PDMR Shareholding
Transatlantic valuation gap is mostly illusory
Director/PDMR Shareholding
SoftBank snub shows London risks losing its listings lustre
SoftBank snub shows London risks losing its listings lustre
Europe Research Roundup: Generali, PPHE Hotel, SKF
CRH’s firm foundations go beyond where it lists
Live Markets: Want to boost your share price? Move to America!